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An Unexpected Abdominal 18F-Fluorodeoxyglucose (FDG)
Uptake on Positron Emission Tomography (PET) in a
Patient with Limited Stage Small Cell Lung Cancer
Lynn Decoster, MD,* Sigrid Stroobants, MD, PhD,† Eric Verbeken, MD, PhD,‡
Kris Nackaerts, MD, PhD,* and Johan Vansteenkiste, MD, PhD*
We report the case of an unexpected 18F-fluorodeoxyglucose-avid
lesion in the right lower abdomen in a patient with otherwise “very
limited” (T1N0) small cell lung cancer (SCLC). Additional imaging
and endoscopic studies showed no abnormality. The patient was
treated for presumed very limited disease SCLC, with resection,
adjuvant chemotherapy, and prophylactic brain irradiation. Follow-up
fusion positron emission tomography-computed tomography re-
vealed an unusual SCLC complication.
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A 61-year-old male patient was referred to our institutionafter a chest radiograph for nonproductive cough had
revealed a right hilar mass. He was an active, 45 pack-years,
smoker. His medical history was unremarkable, except for a
left-sided pneumonia 6 years ago. He had no other symptoms
and clinical examination was normal.
Chest computed tomography (CT) showed a hilar mass
in the right upper lobe (29  20 mm) and enlarged medias-
tinal nodes in the right paratracheal space. Bronchoscopy was
normal, no pathologic diagnosis was obtained. Extrathoracic
conventional imaging was normal as well. On positron emis-
sion tomography (PET), there was intense 18F-fluorodeoxy-
glucose (FDG) uptake in the thoracic lesion (not shown) and
a small hot spot in the right lower abdomen (Figure 1). Visual
correlation with abdominal CT could not pinpoint at an
anatomic lesion and colonoscopy was normal, including the
transition to the ileum and appendix. The clinical diagnosis
was suspected primary lung tumor, with a clinical stage
T1N0M0. After a negative mediastinoscopy, the patient had
a right superior lobectomy with complete mediastinal
lymph node dissection, for a pT1N0 small cell lung cancer
(SCLC) (size 27 mm  26 mm  22 mm). Surgery was
followed by adjuvant chemotherapy (six cycles of carbo-
platin area under the curve  5 on day 1, in combination
with etoposide 100 mg/m2 on days 1–3) and prophylactic
cranial radiotherapy (30 Gy in 15 fractions of 2 Gy). No
thoracic radiotherapy was given.
One year after the initial diagnosis, the patient had an-
orexia and weight loss. Restaging including fusion PET-CT
revealed further increase of uptake in the right lower abdominal
lesion, suggestive of appendix localization (Figure 2). At
exploratory laparoscopy, an abnormal appendix was re-
moved. Histology revealed metastasis of chromogranin-
positive small cell carcinoma, of pulmonary origin, as
confirmed by positive thyroid transcription factor-1 stain-
ing (Figure 3). Recent evaluation including PET-CT
showed no evidence of recurrence 15 months after initial
diagnosis.
DISCUSSION
SCLC has a high tendency to metastasize early in the
course of the disease, and at diagnosis about 70% of patients
have extensive disease. Most commonly, distant spread oc-
curs in the liver, brain, bone, bone marrow, and adrenal
glands. Metastasis to the appendix is extremely rare, and the
literature consists mainly of sporadic case reports.1 Isolated
appendix metastasis is even more unusual, and we retrieved
only one prior case.2
This case also illustrates the accuracy of FDG-PET in
SCLC. The main goal of baseline SCLC staging is to distin-
guish patients with limited disease, candidates for intensive
multimodality treatment, and those with extensive disease,
who will have palliative chemotherapy. Compared with the
key role of PET in the staging of NSCLC, there is no
large-scale evidence in SCLC. Many series, however, point at
the added value of FDG-PET in detection of extensive dis-
ease missed at conventional imaging, except for brain metas-
tasis.3 In one of the largest with 120 patients, FDG-PET
*Respiratory Oncology Unit (Pulmonology) and Leuven Lung Cancer
Group; †Nuclear Medicine; and ‡Pathology, University Hospital Gas-
thuisberg, Leuven, Belgium.
Disclosure: The authors declare no conflict of interest.
Address for correspondence: Johan Vansteenkiste, MD, PhD, Department of
Pulmonology, Herestraat 49, 3000 Leuven, Belgium. E-mail: johan.
vansteenkiste@uz.kuleuven.ac.be
Copyright © 2008 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/08/0302-0174
Journal of Thoracic Oncology • Volume 3, Number 2, February 2008174
resulted in correct upstaging to extensive disease in 10 and
downstaging in three patients.4 Whether FDG-PET will re-
place other more established staging modalities remains to
be determined by larger prospective randomized controlled
studies.
In our patient, the finding of a small FDG-avid lesion in
the right lower abdomen was disregarded based on the knowl-
edge that false-positive FDG uptake over the colonic area is
common, and on the normal results of CT and colonoscopy.
Fusion PET-CT at that time might have been more helpful, as
evolving evidence supports the use of fusion images in
correctly localizing foci with increased FDG uptake, espe-
cially in abdominal staging.5 If the finding had been pursued
by diagnostic laparoscopy initially—to exclude a synchro-
nous second primary tumor or more importantly metastatic
disease—this would have significantly altered our therapeutic
approach.
FIGURE 1. FDG-PET scan at initial staging showing focal
FDG uptake (arrow) in the right lower abdomen.
FIGURE 2. Imaging at restaging. Coronal and axial PET
slices demonstrate further increase of focal FDG uptake in
the right lower abdomen (A, B). Area of increased uptake
was localized to the appendix by fusion PET-CT (C, D).
FIGURE 3. Histology of resection specimen (hematoxylin-
eosin, 12), showing normal mucosal glands (*) and
infiltration of serosa by tumor cells (**) (A). Tumor had posi-
tive chromogranin (B) and thyroid transcription factor-1
staining (C).
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